Clinical trial / 2014
Dietary protein restriction markedly increases circulating FGF21 levels in humans and rodents.
Researchers evaluated the impact of dietary protein restriction versus energy restriction on FGF21 expression and metabolic responses in rodents and humans. Circulating FGF21 increased 10-fold in mice and rats on a low-protein diet, with liver Fgf21 expression rising within 24 hours. In humans, circulating FGF21 levels increased dramatically following 28 days on a low-protein diet. In mice, FGF21-deficient animals lacked the alterations in food intake, energy expenditure, and body weight gain observed in wild-type mice on a low-protein diet.
- Study type
- Intervention study (human and rodent experiments)
- Who was studied
- Humans (sample size not stated), as well as mice and rats
- What was measured
- Circulating FGF21 levels, hepatic Fgf21 expression, food intake, energy expenditure, and body weight gain
THE PAPER
FGF21 is an endocrine signal of protein restriction.
Laeger T, Henagan TM, Albarado DC, Redman LM, Bray GA, Noland RC, Münzberg H, Hutson SM, Gettys TW, Schwartz MW, Morrison CD. J Clin Invest, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.